BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38319579)

  • 1. Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of Pancreatic Cancer Cells.
    Chumak V; Rajacharya GH; Singh PK
    Methods Mol Biol; 2024; 2755():191-200. PubMed ID: 38319579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells.
    Gunda V; Kumar S; Dasgupta A; Singh PK
    Methods Mol Biol; 2018; 1742():95-105. PubMed ID: 29330793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression.
    Song H; Qiu Z; Wang Y; Xi C; Zhang G; Sun Z; Luo Q; Shen C
    Int J Biol Sci; 2023; 19(1):225-241. PubMed ID: 36594102
    [No Abstract]   [Full Text] [Related]  

  • 5. Nuclear GRP78 Promotes Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Ductal Adenocarcinoma.
    Zhao T; Jiang T; Li X; Chang S; Sun Q; Kong F; Kong X; Wei F; He J; Hao J; Xie K
    Clin Cancer Res; 2023 Dec; 29(24):5183-5195. PubMed ID: 37819952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration.
    Liu Z; Jia X; Duan Y; Xiao H; Sundqvist KG; Permert J; Wang F
    Cancer Biol Ther; 2013 May; 14(5):428-35. PubMed ID: 23377827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
    Chaika NV; Gebregiworgis T; Lewallen ME; Purohit V; Radhakrishnan P; Liu X; Zhang B; Mehla K; Brown RB; Caffrey T; Yu F; Johnson KR; Powers R; Hollingsworth MA; Singh PK
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13787-92. PubMed ID: 22869720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor modulates HIF-1α levels and diminishes 5-FU sensitivity in 5-FU resistant pancreatic cells by altering the anabolic glucose metabolism.
    Xiang F; Luo F
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23487. PubMed ID: 37718545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells.
    He G; Jiang Y; Zhang B; Wu G
    Asia Pac J Clin Nutr; 2014; 23(1):174-80. PubMed ID: 24561986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible Factor-1α Mediates Hyperglycemia-induced Pancreatic Cancer Glycolysis.
    Cheng L; Qin T; Ma J; Duan W; Xu Q; Li X; Han L; Li W; Wang Z; Zhang D; Ma Q; Lei J
    Anticancer Agents Med Chem; 2019; 19(12):1503-1512. PubMed ID: 31241439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
    Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
    BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Myocardial Hypoxia-Inducible Factor-1α Compromises Metabolic Adaptation and Impairs Cardiac Function in Patients With Cyanotic Congenital Heart Disease During Puberty.
    Liu Y; Luo Q; Su Z; Xing J; Wu J; Xiang L; Huang Y; Pan H; Wu X; Zhang X; Li J; Yan F; Zhang H
    Circulation; 2021 Jun; 143(23):2254-2272. PubMed ID: 33663226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
    Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
    Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
    Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
    Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
    World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology.
    Kierans SJ; Taylor CT
    J Physiol; 2021 Jan; 599(1):23-37. PubMed ID: 33006160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988.
    Fan G; Bo J; Wan R; Peng M; Luan Y; Deng M; Xu L
    Cancer Biother Radiopharm; 2015 May; 30(4):160-8. PubMed ID: 25853522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation.
    Akakura N; Kobayashi M; Horiuchi I; Suzuki A; Wang J; Chen J; Niizeki H; Kawamura Ki ; Hosokawa M; Asaka M
    Cancer Res; 2001 Sep; 61(17):6548-54. PubMed ID: 11522653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
    Seo J; Yun JE; Kim SJ; Chun YS
    Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.